Alibaba ADRs listed in Europe are up nearly 10%, marking their strongest single-day gain since September 2025. The rally is being driven by growing optimism ahead of the company's upcoming earnings release, as well as a broader rotation of capital into Chinese internet stocks. Investors are increasingly seeking cheaper exposure to the AI theme following the recent surge—and the latest sharp pullback—in semiconductor stocks across the United States, South Korea, and Taiwan.
Why is Alibaba rising?
The immediate catalyst was Alibaba's pre-earnings briefing with analysts, which improved expectations for the upcoming results. Investors reacted positively to signs that losses in the highly competitive instant-commerce business narrowed during the quarter, easing concerns over margin pressure. Equally important, Alibaba appears capable of maintaining profitability while continuing to invest in high-growth businesses, including cloud computing, artificial intelligence, and digital commerce.
Alibaba's rally also reflects a broader capital rotation across Asian equity markets. After a prolonged rally in semiconductor stocks, investors have begun reducing exposure to the more expensive markets in the United States, South Korea, and Taiwan, shifting capital toward relatively undervalued Chinese megacaps. The simultaneous gains in Tencent and JD.com suggest this is not merely an Alibaba-specific story, but rather an attempt by investors to re-rate China's internet sector after a prolonged period of underperformance.
Alibaba ADR (AHLA.DE) chart
Despite today's strong rebound, Alibaba shares are still trading nearly 40% below their all-time highs, while overall sentiment toward Chinese assets remains subdued. A positive earnings surprise could reinforce the recovery and potentially lift the stock back above $100 per share.

Source: xStation5
Daily Summary: A sell-off with a spin-off
US OPEN: The market extends losses as investor concerns grow
Market Wrap: European indices decline amid US - Iran tensions📉 Semiconductors under pressure
Netflix disappoints Wall Street 🚩 Stock drops 9% after disappointing outlook
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.